Related Experiment Videos

Vaccines for the control of HIV/AIDS

F Gotch¹, A Rutebemberwa, G Jones

¹Department of Immunology, Imperial College of Science and Medicine, London, UK. f.gotch@ic.ac.uk

Tropical Medicine & International Health : TM & IH

|August 30, 2000

Abstract:

This review discusses the feasibility of an HIV vaccine and describes the history, efficacy and potential to succeed of old and new vaccine concepts.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy.

Clinical and experimental immunology·2012

Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial.

Vaccine·2011

Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals.

Clinical and experimental immunology·2009

Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers.

Vaccine·2008

A mathematical model comparing solute kinetics in low- and high-BMI hemodialysis patients.

The International journal of artificial organs·2007

Evaluation of aldrithiol-2-inactivated preparations of HIV type 1 subtypes A, B, and D as reagents to monitor T cell responses.

AIDS research and human retroviruses·2007

See all related articles